<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN" "JATS-archive-oasis-article1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="efs22287" dtd-version="1.1" xml:lang="en" article-type="article-commentary">
<front>
<journal-meta>
<journal-id journal-id-type="doi">10.1002/(ISSN)1831-4732</journal-id>
<journal-id journal-id-type="publisher-id">EFS2</journal-id>
<journal-title-group>
<journal-title xml:lang="en">EFSA Journal</journal-title>
<abbrev-journal-title abbrev-type="publisher" xml:lang="en">EFSA Journal</abbrev-journal-title>
</journal-title-group>
<issn publication-format="ppub">1831-4732</issn>
<issn publication-format="epub">1831-4732</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.2903/j.efsa.2011.2287</article-id>
<article-id pub-id-type="publisher-id">EFS22287</article-id>
<article-categories>
<subj-group subj-group-type="overline" xml:lang="en"><subject>Opinion</subject></subj-group>
<subj-group subj-group-type="heading" xml:lang="en"><subject>Opinions</subject></subj-group>
</article-categories>
<title-group>
<article-title xml:lang="en">Scientific Opinion on the safety of ‘Glavonoid®’, an extract derived from the roots or rootstock of Glycyrrhiza glabra L., as a Novel Food ingredient</article-title>
<alt-title alt-title-type="right-running-head">Safety of ‘Glavonoid®’</alt-title>
</title-group>
<contrib-group>
<contrib id="efs22287-cr-0001" contrib-type="author"><collab collab-type="authors">EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)</collab>
</contrib>
</contrib-group>
<pub-date pub-type="epub">
<day>21</day>
<month>07</month>
<year>2011</year>
</pub-date>
<pub-date pub-type="ppub">
<day>21</day>
<month>07</month>
<year>2011</year>
</pub-date>
<volume>9</volume>
<issue seq="190">7</issue>
<issue-id pub-id-type="doi">10.1002/efs2.2011.9.issue-7</issue-id>
<elocation-id>2287</elocation-id>
<permissions>
<copyright-statement content-type="issue-copyright">© European Food Safety Authority</copyright-statement>
<copyright-statement content-type="article-copyright">© 2011 European Food Safety Authority</copyright-statement>
</permissions>
<self-uri xlink:href="file:efs22287.pdf" content-type="pdf"/><abstract xml:lang="en" abstract-type="main" id="efs22287-abs-0001">
<title>Abstract</title>
<p xml:lang="en">Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on the safety of ‘Glavonoid’ as a food ingredient in the context of Regulation (EC) No 258/97 taking into account the comments and objections of a scientific nature raised by Member States. Glavonoid is an extract derived from the root or rootstock of <italic>Glycyrrhiza glabra</italic> L. by extraction with ethanol followed by further extraction with medium‐chain triglycerides. The applicant provided sufficient information on the specification, production, composition and the stability of Glavonoid. The applicant intends to market Glavonoid as food supplements and as an ingredient for fruit juices, yoghurts and yoghurt drinks up to a dose of 300 mg per day to the general adult population. A 90‐day rat study showed a lowest observed adverse effect level (LOAEL) at a dose of 400 mg/kg bw per day. Prothrombin‐time and activated partial thromboplastin time (APTT) were analysed using a Benchmark Dose (BMD) modelling approach. The BMD lower confidence limit (BMDL<sub>05</sub>) for this study derived from APTT data is 167 mg/kg bw per day. There are no concerns related to genotoxicity. Studies on reproductive and developmental toxicity were not provided. Extrapolation of the BMDL<sub>05</sub> from the rat study to a maximum intake for a 70 kg person results in 117 mg Glavonoid/day. The human studies provided do not raise safety concerns. The Panel considers that the human studies are consistent with the maximum level derived from the BMD approach. The Panel considers that there are no concerns related to genotoxicity. The safety of Glavonoid for pregnant and breast‐feeding women has not been established. The Panel concludes that the novel food ingredient Glavonoid is safe for the general adult population up to 120 mg/day.</p>
</abstract>
<kwd-group kwd-group-type="author-generated" xml:lang="en">
<kwd id="efs22287-kwd-0001">Glycyrrhiza glabra</kwd>
<kwd id="efs22287-kwd-0002">liquorice</kwd>
<kwd id="efs22287-kwd-0003">ethanolic extract</kwd>
</kwd-group>
<counts>
<page-count count="27"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>July 2011</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATS version:6.3.6 mode:remove_FC converted:25.01.2024</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation"><mixed-citation publication-type="self-citation" id="efs22287-selfcit-0001"><collab collab-type="authors">EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)</collab>
; <article-title xml:lang="en">Scientific Opinion on the safety of ‘Glavonoid®', an extract derived from the roots or rootstock of Glycyrrhiza glabra L., as a Novel Food ingredient on request from the European Commission</article-title>. <source xml:lang="en">EFSA Journal</source> <year>2011</year>;<volume>9</volume>(<issue>7</issue>):2287. [27 pp.]. doi:<ext-link ext-link-type="doi" xlink:href="10.2903/j.efsa.2011.2287">10.2903/j.efsa.2011.2287</ext-link>.</mixed-citation></p>
<fn-group>
<fn id="efs22287-note-0001" xml:lang="en"><p>Panel members: Carlo V. Agostoni, Jean‐Louis Bresson, Susan Fairweather‐Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser‐Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen</p></fn>
<fn id="efs22287-note-0002" xml:lang="en"><p>Correspondence: <email>nda@efsa.europa.eu</email></p></fn>
<fn id="efs22287-note-0003" xml:lang="en"><p>Acknowledgement: The Panel wishes to thank for the preparatory work on this scientific opinion: The members of the Working Group on Novel Foods: Karl‐Heinz Engel, Ines Golly, Marina Heinonen, Pagona Lagiou, Rosangela Marchelli, Bevan Moseley, Monika Neuhäuser‐Berthold, Annette Pöting, Seppo Salminen, Hendrik Van Loveren and Hans Verhagen; EFSA's staff members José Cortiñas Abrahantes and Wolfgang Gelbmann for the support provided to this scientific opinion.</p></fn>
<fn id="efs22287-note-0004" xml:lang="en"><p>Adoption date: 30 June 2011</p></fn>
<fn id="efs22287-note-0005" xml:lang="en"><p>Published date: 21 July 2011</p></fn>
<fn id="efs22287-note-0008" xml:lang="en"><p>Question number: EFSA‐Q‐2009‐00749</p></fn>
<fn id="efs22287-note-0009" xml:lang="en"><p>On request from: European Commission</p></fn>
</fn-group>
</notes>
</front>

<back>
<ref-list id="efs22287-bibl-0001" content-type="uncited-references">
<title>References</title>
<ref id="efs22287-bib-0001"><mixed-citation publication-type="journal" id="efs22287-cit-0001"><string-name><surname>Aoki</surname> <given-names>F</given-names></string-name>, <string-name><surname>Nakagawa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kitano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ikematsu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nakamura</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yokota</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tominaga</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Arai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mae</surname> <given-names>T</given-names></string-name>, <year>2007</year>. <article-title xml:lang="en">Clinical Safety of Liquorice Flavonoid Oil (LFO) and Pharmacokinetics of Glabridin in Healthy Humans</article-title>. <source xml:lang="en">Journal of the American College of Nutrition</source> <volume>26</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>218</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0002"><mixed-citation publication-type="miscellaneous" id="efs22287-cit-0002"><collab collab-type="authors">Arai</collab>
, <year>2004</year>. <article-title xml:lang="en">Study protocol. Confirmation of the body fat reducing effect of LFO</article-title>. <article-title xml:lang="en">Effective dose finding study</article-title>. Protocol No. 16139.</mixed-citation></ref>
<ref id="efs22287-bib-0003"><mixed-citation publication-type="miscellaneous" id="efs22287-cit-0003"><string-name><surname>Asakura</surname> <given-names>M</given-names></string-name>, <year>2003</year>. <article-title xml:lang="en">Chromosomal Aberration Test of Liquorice Flavonoid Oil in Cultured Mammalian Cells</article-title>. Study No. 7352. Study Report.</mixed-citation></ref>
<ref id="efs22287-bib-0004"><mixed-citation publication-type="journal" id="efs22287-cit-0004"><string-name><surname>Au</surname> <given-names>N</given-names></string-name> and <string-name><surname>Rettie</surname> <given-names>E</given-names></string-name>, <year>2008</year>. <article-title xml:lang="en">Pharmacogenomics of 4‐hydroxycoumarin anticoagulants</article-title>. <source xml:lang="en">Drug Metabolism Reviews</source> <volume>40</volume>, <fpage>355</fpage>–<lpage>375</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0005"><mixed-citation publication-type="journal" id="efs22287-cit-0005"><string-name><surname>Cartier</surname> <given-names>A</given-names></string-name>, <string-name><surname>Malo</surname> <given-names>J‐L</given-names></string-name>, <string-name><surname>Labrecque</surname> <given-names>M</given-names></string-name>, <year>2002</year>. <article-title xml:lang="en">Occupational asthma due to liquorice roots</article-title>. <source xml:lang="en">Allergy</source> <volume>57</volume>, <fpage>863</fpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0006"><mixed-citation publication-type="journal" id="efs22287-cit-0006"><collab collab-type="authors">EC (European Commission)</collab>
, <year>1997</year>. <article-title xml:lang="en">Commission Recommendation 97/618/EC of 29 July 1997 concerning the scientific aspects and the presentation of information necessary to support applications for the placing on the market of novel foods and novel food ingredients and the preparation of initial assessment reports under Regulation (EC) No 258/97 of the European Parliament and of the Council</article-title>. <source xml:lang="en">Official Journal of the European Communities</source> <volume>L 253</volume>, 16.09.1997, p. <fpage>1</fpage>–<lpage>36</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0007"><mixed-citation publication-type="journal" id="efs22287-cit-0007"><collab collab-type="authors">EFSA (European Food Safety Authority)</collab>
, <year>2009</year>. <article-title xml:lang="en">Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment</article-title>. <source xml:lang="en">The EFSA Journal (2009)</source> <volume>1150</volume>, <fpage>1</fpage>–<lpage>722</lpage> External expert of the EFSA Scientific Committee.</mixed-citation></ref>
<ref id="efs22287-bib-0008"><mixed-citation publication-type="journal" id="efs22287-cit-0008"><string-name><surname>Gonzales‐Gutierrez</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Sanchez‐Fernandez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Esteban‐Lopez</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Sempere‐Ortells</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Diaz‐Alperi</surname> <given-names>P</given-names></string-name>, <year>2000</year>. <article-title xml:lang="en">Allergy to anis</article-title>. <source xml:lang="en">Allergy</source> <volume>55</volume>, <fpage>195</fpage>–<lpage>204</lpage></mixed-citation></ref>
<ref id="efs22287-bib-0009"><mixed-citation publication-type="journal" id="efs22287-cit-0009"><string-name><surname>Goetz</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Kamal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ames</surname> <given-names>MM.</given-names></string-name>, <year>2008</year>. <article-title xml:lang="en">Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response</article-title>. <source xml:lang="en">Clin Pharmacol Ther</source>. 2008 Jan;<volume>83</volume>(<issue>1</issue>):<fpage>160</fpage>–<lpage>6</lpage>. Review.</mixed-citation></ref>
<ref id="efs22287-bib-0010"><mixed-citation publication-type="miscellaneous" id="efs22287-cit-0010"><string-name><surname>Hikino</surname> <given-names>H</given-names></string-name>, <year>1985</year>, <article-title xml:lang="en">Recent research on oriental medicinal plants</article-title>.</mixed-citation></ref>
<ref id="efs22287-bib-0011"><mixed-citation publication-type="book" id="efs22287-cit-0011"><string-name><surname>Ikematsu</surname> <given-names>H</given-names></string-name>, <year>2004a</year>. <source xml:lang="en">Study Report: Safety Study of LFO in Single‐dose Ingestion</source>. Protocol No. H16‐KA0212. <publisher-name>Total Technological Consultant, Co., Ltd.</publisher-name></mixed-citation></ref>
<ref id="efs22287-bib-0012"><mixed-citation publication-type="book" id="efs22287-cit-0012"><string-name><surname>Ikematsu</surname> <given-names>H</given-names></string-name>, <year>2004b</year>. <article-title xml:lang="en">Study Report</article-title>. <source xml:lang="en">Safety Study of LFO in I‐week Repeated‐dose Ingestion</source>. Protocol No. 161 12. <publisher-name>Total Technological Consultant, Co., Ltd.</publisher-name></mixed-citation></ref>
<ref id="efs22287-bib-0013"><mixed-citation publication-type="book" id="efs22287-cit-0013"><string-name><surname>Ikematsu</surname> <given-names>H</given-names></string-name>, <year>2005</year>. <article-title xml:lang="en">Study Report</article-title>. <source xml:lang="en">Safety Study of LFO in 4‐week Repeated‐dose Ingestion</source>. Protocol No. 16113. <publisher-name>Total Technological Consultant, Co., Ltd.</publisher-name></mixed-citation></ref>
<ref id="efs22287-bib-0014"><mixed-citation publication-type="book" id="efs22287-cit-0014"><string-name><surname>Ikematsu</surname> <given-names>H</given-names></string-name> and <string-name><surname>Nakamura</surname> <given-names>H</given-names></string-name>, <year>2005</year>. <article-title xml:lang="en">Study Report</article-title>. <source xml:lang="en">Safety Study of LFO (1800 mg) in 4‐week Repeated‐ose Ingestion</source>. Protocol No. 17218. <publisher-name>Total Technological Consultant, Co., Ltd.</publisher-name></mixed-citation></ref>
<ref id="efs22287-bib-0015"><mixed-citation publication-type="journal" id="efs22287-cit-0015"><string-name><surname>Ito</surname> <given-names>C</given-names></string-name>, <string-name><surname>Oi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hashimoto</surname> <given-names>T</given-names></string-name>, <string-name><surname>Nakabayashi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Aoki</surname> <given-names>F</given-names></string-name>, <string-name><surname>Tominaga</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yokota</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hosoe</surname> <given-names>K</given-names></string-name> and <string-name><surname>Kanazawa</surname> <given-names>K</given-names></string-name>, <year>2007</year>. <article-title xml:lang="en">Absorption of dietary liquorice isoflavan glabridin to blood circulation in rats</article-title>. <source xml:lang="en">Journal of Nutritional Science and Vitaminology</source> <volume>53</volume>, <fpage>358</fpage>–<lpage>365</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0016"><mixed-citation publication-type="journal" id="efs22287-cit-0016"><string-name><surname>Jin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Desta</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Stearns</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ward</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ho</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Skaar</surname> <given-names>T</given-names></string-name>, <string-name><surname>Storniolo</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Araba</surname> <given-names>A</given-names></string-name>, <string-name><surname>Blanchard</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ullmer</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hayden</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lemler</surname> <given-names>S</given-names></string-name>, <string-name><surname>Weinshilboum</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Rae</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Hayes</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Flockhart</surname> <given-names>DA</given-names></string-name>, <year>2005</year>. <article-title xml:lang="en">CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment</article-title>. <source xml:lang="en">J Natl Cancer Inst</source>. <volume>97</volume>(<issue>1</issue>):<fpage>30</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0017"><mixed-citation publication-type="miscellaneous" id="efs22287-cit-0017"><string-name><surname>Kamigaito</surname> <given-names>T</given-names></string-name>, <year>2003</year>. <article-title xml:lang="en">Reverse Mutation Test of Liquorice Flavonoid Oil in Bacteria</article-title>. <article-title xml:lang="en">Study No 6208</article-title>. Final Report.</mixed-citation></ref>
<ref id="efs22287-bib-0018"><mixed-citation publication-type="book" id="efs22287-cit-0018"><string-name><surname>Kawabe</surname> <given-names>M</given-names></string-name>, <year>2004</year>. <source xml:lang="en">90‐day repeated dose toxicity study of liquorice flavonoid oil in rats</source>. Study No. 0326. Final Report. <publisher-name>Daiyu‐kai Institute of Medical Science</publisher-name>. <publisher-loc>Ichinomiya, Japan</publisher-loc>.</mixed-citation></ref>
<ref id="efs22287-bib-0019"><mixed-citation publication-type="journal" id="efs22287-cit-0019"><string-name><surname>Kent</surname> <given-names>U</given-names></string-name>, <string-name><surname>Aviram</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rosenblat</surname> <given-names>M</given-names></string-name> and <string-name><surname>Hollenberg</surname> <given-names>PF</given-names></string-name>, <year>2002</year>. <article-title xml:lang="en">The liquorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450s 3A4, 2B6 and 2C9</article-title>. <source xml:lang="en">Drug Metabolism and Disposition</source> <volume>30</volume>, <fpage>709</fpage>–<lpage>715</lpage></mixed-citation></ref>
<ref id="efs22287-bib-0020"><mixed-citation publication-type="journal" id="efs22287-cit-0020"><string-name><surname>Matsunaga</surname> <given-names>K</given-names></string-name> and <string-name><surname>Fujisawa</surname> <given-names>Y</given-names></string-name>, <year>1995</year>. <article-title xml:lang="en">2 cases with allergic contact dermatitis due to whitening agents</article-title>. <source xml:lang="en">Aesthetic Dermatology</source> <volume>5</volume>: <fpage>81</fpage>–<lpage>86</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0021"><mixed-citation publication-type="journal" id="efs22287-cit-0021"><string-name><surname>Nakagawa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hidaka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kitano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Asakura</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kamigaito</surname> <given-names>T</given-names></string-name>, <string-name><surname>Noguchi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hosoe</surname> <given-names>K</given-names></string-name>, <year>2008a</year>. <article-title xml:lang="en">Genotoxicity studies on liquorice flavonoid oil (LFO)</article-title>. <source xml:lang="en">Food and Chemical Toxicology</source> <volume>46</volume>(<issue>7</issue>):<fpage>2525</fpage>–<lpage>32</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0022"><mixed-citation publication-type="journal" id="efs22287-cit-0022"><string-name><surname>Nakagawa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kitano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kishida</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hidaka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Nabae</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kawabe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hosoe</surname> <given-names>K</given-names></string-name>, <year>2008b</year>. <article-title xml:lang="en">90‐Day repeated‐dose toxicity study of liquorice flavonoid oil (LFO) in rats</article-title>. <source xml:lang="en">Food and Chemical Toxicology</source> <volume>46</volume>(<issue>7</issue>):<fpage>2349</fpage>–<lpage>57</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0023"><mixed-citation publication-type="journal" id="efs22287-cit-0023"><string-name><surname>Nishioka</surname> <given-names>K</given-names></string-name> and <string-name><surname>Seguchi</surname> <given-names>T</given-names></string-name>, <year>1999</year>. <article-title xml:lang="en">Contact allergy due to oil‐soluble liquorice extracts in cosmetic products</article-title>. <source xml:lang="en">Contact Dermatitis</source> <volume>40</volume>: <fpage>56</fpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0024"><mixed-citation publication-type="miscellaneous" id="efs22287-cit-0024"><string-name><surname>Noguchi</surname> <given-names>T</given-names></string-name>, <year>2003a</year>. <article-title xml:lang="en">Bone Marrow Micronucleus test of Liquorice Flavonoid Oil with Rats</article-title>. Study No. 7038, Study Report.</mixed-citation></ref>
<ref id="efs22287-bib-0025"><mixed-citation publication-type="miscellaneous" id="efs22287-cit-0025"><string-name><surname>Noguchi</surname> <given-names>T</given-names></string-name>, <year>2003b</year>. <article-title xml:lang="en">Liver and Peripheral Blood Micronucleus Test of Liquorice Flavonoid Oil with Rats</article-title>. Study No. 7035, Study Report.</mixed-citation></ref>
<ref id="efs22287-bib-0026"><mixed-citation publication-type="journal" id="efs22287-cit-0026"><string-name><surname>Nomura</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fukai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Akiyama</surname> <given-names>T</given-names></string-name>, <year>2002</year>. <article-title xml:lang="en">Chemistry of phenolic compounds of liquorice (Glycyrrhiza species) and their estrogenic and cytotoxic activities</article-title>. <source xml:lang="en">Pure and Applied Chemistry</source> <volume>74</volume> (<issue>7</issue>):<fpage>1199</fpage>–<lpage>1206</lpage></mixed-citation></ref>
<ref id="efs22287-bib-0027"><mixed-citation publication-type="journal" id="efs22287-cit-0027"><string-name><surname>O'Connell</surname> <given-names>RL</given-names></string-name>, <string-name><surname>White</surname> <given-names>IR</given-names></string-name>, <string-name><surname>White</surname> <given-names>JM</given-names></string-name>, <string-name><surname>McFadden</surname> <given-names>JP</given-names></string-name>, <year>2008</year>. <article-title xml:lang="en">Liquorice extract in a cosmetic product causing contact allergy</article-title>. <source xml:lang="en">Contact Dermatitis</source> <volume>59</volume>(<issue>1</issue>):<fpage>52</fpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0028"><mixed-citation publication-type="journal" id="efs22287-cit-0028"><string-name><surname>Somjen</surname> <given-names>D</given-names></string-name>, <string-name><surname>Knoll</surname> <given-names>E</given-names></string-name>, <string-name><surname>Vaya</surname> <given-names>J</given-names></string-name>, <string-name><surname>Stern</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tamir</surname> <given-names>S</given-names></string-name>, <year>2004</year>. <article-title xml:lang="en">Estrogen‐like activity of liquorice root constituents; glabridin and glabrene, in vascular tissues in vitro and in vivo</article-title>. <source xml:lang="en">Journal of Steroid Biochemistry and Molecular Biology</source> <volume>91</volume>(<issue>3</issue>):<fpage>147</fpage>–<lpage>155</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0029"><mixed-citation publication-type="journal" id="efs22287-cit-0029"><string-name><surname>Tamir</surname> <given-names>S</given-names></string-name>, <string-name><surname>Eizenberg</surname> <given-names>M</given-names></string-name>, <string-name><surname>Somjen</surname> <given-names>D</given-names></string-name>, <string-name><surname>Stern</surname> <given-names>N</given-names></string-name>, <string-name><surname>Shelach</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kaye</surname> <given-names>A</given-names></string-name>, <string-name><surname>Vaya</surname> <given-names>J.</given-names></string-name> <year>2000</year>. <article-title xml:lang="en">Estrogenic and antiproliferative properties of glabridin from liquorice in human breast cancer cells</article-title>. <source xml:lang="en">Cancer Research</source> <volume>60</volume>(<issue>20</issue>):<fpage>5704</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0030"><mixed-citation publication-type="journal" id="efs22287-cit-0030"><string-name><surname>Tamir</surname> <given-names>S</given-names></string-name>, <string-name><surname>Eizenberg</surname> <given-names>M</given-names></string-name>, <string-name><surname>Somjen</surname> <given-names>D</given-names></string-name>, <string-name><surname>Izrael</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vaya</surname> <given-names>J</given-names></string-name>, <year>2001</year>. <article-title xml:lang="en">Estrogen‐like activity of glabrene and other constituents isolated from liquorice root</article-title>. <source xml:lang="en">Journal of Steroid Biochemistry and Molecular Biology</source> <volume>78</volume>(<issue>3</issue>):<fpage>291</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0031"><mixed-citation publication-type="journal" id="efs22287-cit-0031"><string-name><surname>Tominaga</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mae</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kitano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sakamoto</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ikematsu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nakagawa</surname> <given-names>K</given-names></string-name>, <year>2006</year>. <article-title xml:lang="en">Liquorice flavonoid oil effects body weight loss by reduction of body fat mass in overweight subjects</article-title>. <source xml:lang="en">Journal of Health Science</source> <volume>52</volume>(<issue>6</issue>):<fpage>672</fpage>–<lpage>683</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0032"><mixed-citation publication-type="book" id="efs22287-cit-0032"><collab collab-type="authors">UKDA</collab>
, <string-name><surname>Henderson</surname> <given-names>L</given-names></string-name>, <string-name><surname>Irving</surname> <given-names>K</given-names></string-name>, <string-name><surname>Gregory</surname> <given-names>J</given-names></string-name>, <year>2002</year>. <article-title xml:lang="en">National Diet and Nutrition Survey: Adult aged 19 to 64 Years</article-title>. <source xml:lang="en">A survey carried in Great Britain on behalf of the Food Standards Agency</source>, <publisher-name>Office for National Statistics and Medical Research, Council Human Nutrition Research</publisher-name>.</mixed-citation></ref>
<ref id="efs22287-bib-0033"><mixed-citation publication-type="book" id="efs22287-cit-0033"><string-name><surname>Yoshino</surname> <given-names>H</given-names></string-name>, <year>2004</year>. <source xml:lang="en">Rat Medium‐term Liver Carcinogenesis Bioassay of Liquorice Flavonoid Oil</source>. Study No. 0406. <publisher-name>DIMS Institute of Medical Science Inc.</publisher-name> English translation dated April 19, 2005.</mixed-citation></ref>
<ref id="efs22287-bib-0034"><mixed-citation publication-type="journal" id="efs22287-cit-0034"><string-name><surname>Zhou</surname>, <given-names>S</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>E</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>M</given-names></string-name>, <year>2005a</year>. <article-title xml:lang="en">Clinical outcomes and management of mechanism‐based inhibition of cytochrome P4503A4</article-title>. <source xml:lang="en">Therap Clin Risk Manag</source>. <volume>1</volume>(<issue>1</issue>): <fpage>3</fpage>–<lpage>13</lpage>.</mixed-citation></ref>
<ref id="efs22287-bib-0035"><mixed-citation publication-type="journal" id="efs22287-cit-0035"><string-name><surname>Zhou</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yung Chan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cher Goh</surname> <given-names>B</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>E</given-names></string-name>, <string-name><surname>Duan</surname> <given-names>W</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>M</given-names></string-name>, <string-name><surname>McLeod</surname> <given-names>HL</given-names></string-name>, 2005b. <article-title xml:lang="en">Mechanism‐based inhibition of cytochrome P450 3A4 by therapeutic drugs</article-title> <source xml:lang="en">Clin Pharmacokinet</source>. <year>2005</year>;<volume>44</volume>(<issue>3</issue>):<fpage>279</fpage>–<lpage>304</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>